64 results
Page 3 of 4
8-K
EX-2.1
1no8ix6
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
424B5
srw32z kegisyiy9w
15 Apr 20
Prospectus supplement for primary offering
5:19pm
8-K/A
EX-99.2
zyw 93b10i
22 Jan 20
Financial Statements and Exhibits
8:52am
8-K
EX-10.3
9hq wt2sx
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
424B3
qwnpq2a107jk4ff3xw47
6 Nov 19
Prospectus supplement
9:15am
425
EX-3.1
knfvik
30 Oct 19
Business combination disclosure
12:00am
8-K
EX-3.1
j1d6mjdn
30 Oct 19
Entry into a Material Definitive Agreement
12:00am
S-4/A
EX-10.35
od99kci3rnp o9a
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
EX-10.45
concu
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.37
oq1sdhupzrmk
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.38
xv8k43lj
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
8-K
EX-2.1
1p0c2tcnav a2b0h
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
8-K
EX-2.5
8thxqbddq4hynklmhgs6
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am